Skip to main content
Erschienen in: Journal of Clinical Immunology 3/2010

01.05.2010

Investigation of Functional IL-10 Gene Polymorphism and IL-10 Levels in Acute Graft-Versus-Host Disease

verfasst von: Renata Gonçalves Resende, Jeane de Fátima Correia-Silva, Telma Cristina Arão, Tarcília Aparecida Silva, Mauro Henrique Nogueira Guimarães Abreu, Henrique Bittencourt, Ricardo Santiago Gomez

Erschienen in: Journal of Clinical Immunology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Graft-versus-host disease (GVHD) represents a major complication in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. Although studies have been conducted concerning the investigation of cytokine polymorphisms in the development of acute GVHD (aGVHD), the contribution of recipients and donors as regards cytokine levels has not yet been thoroughly assessed.

Objective

The aim of this study was to investigate the impact of IL-10 polymorphisms on cytokine levels in blood and saliva, in addition to the occurrence and severity of aGVHD.

Methods

Fifty-eight consecutive allo-HSCT recipients and their donors were included in this prospective study. Saliva and/or blood samples were obtained from recipients and donors to determine IL10 polymorphisms. The IL-10 levels in the blood and saliva were also assessed. The samples were collected from seven days before transplant (day −7) to 100 days after allo-HSCT (day +100), once a week or until the death of recipient.

Results

No association was found between recipient and donor IL10 polymorphism and IL-10 levels in the saliva with aGVHD. In contrast, IL-10 levels in the blood were associated with the occurrence of aGVHD. The high producer phenotype in the recipient was also associated with high levels of IL-10 in the blood and saliva.

Conclusion

Although IL10 polymorphisms were not associated with the occurrence and severity of aGVHD, the genetic background of the recipient did in fact influence the production of the cytokine. Furthermore, as IL-10 levels in the blood were associated with the disease development, this parameter may well be a useful predictor of aGVHD development.
Literatur
1.
Zurück zum Zitat Ferrara JL. Advances in the clinical management of GVHD. Best Pract Res Clin Haematol. 2008;21(4):677–82.CrossRefPubMed Ferrara JL. Advances in the clinical management of GVHD. Best Pract Res Clin Haematol. 2008;21(4):677–82.CrossRefPubMed
2.
Zurück zum Zitat Markey KA, MacDonald KP, Hill GR. Impact of cytokine gene polymorphisms on graft-vs-host disease. Tissue Antigens. 2008;72(6):507–16.CrossRefPubMed Markey KA, MacDonald KP, Hill GR. Impact of cytokine gene polymorphisms on graft-vs-host disease. Tissue Antigens. 2008;72(6):507–16.CrossRefPubMed
3.
Zurück zum Zitat Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev Mol Med. 2007;9(29):1–19.CrossRefPubMed Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev Mol Med. 2007;9(29):1–19.CrossRefPubMed
4.
Zurück zum Zitat Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease. Blood Rev. 2003;17(4):187–94.CrossRefPubMed Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease. Blood Rev. 2003;17(4):187–94.CrossRefPubMed
5.
Zurück zum Zitat Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304.CrossRefPubMed Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304.CrossRefPubMed
6.
Zurück zum Zitat Ferrara JL, Yanik G. Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies. Clin Adv Hematol Oncol. 2005;3(5):415–9. 428.PubMed Ferrara JL, Yanik G. Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies. Clin Adv Hematol Oncol. 2005;3(5):415–9. 428.PubMed
7.
Zurück zum Zitat Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol. 2000;61:863–6.CrossRefPubMed Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol. 2000;61:863–6.CrossRefPubMed
8.
Zurück zum Zitat Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Ver Immunol. 1993;11:165–90.CrossRef Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Ver Immunol. 1993;11:165–90.CrossRef
9.
Zurück zum Zitat Middleton PG, Taylor PRA, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood. 1998;92:3943–8.PubMed Middleton PG, Taylor PRA, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood. 1998;92:3943–8.PubMed
10.
Zurück zum Zitat Rocha V, Franco RF, Porcher R, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;100:3908–18.CrossRefPubMed Rocha V, Franco RF, Porcher R, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;100:3908–18.CrossRefPubMed
11.
Zurück zum Zitat Tseng LH, Storer B, Petersdorf E, Lin MT, Chien JW, Grogan BM, et al. IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation. Transplantation. 2009;87(5):704–10.CrossRefPubMed Tseng LH, Storer B, Petersdorf E, Lin MT, Chien JW, Grogan BM, et al. IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation. Transplantation. 2009;87(5):704–10.CrossRefPubMed
12.
Zurück zum Zitat Koch W, Kastrati A, Bottiger C, Mehilli J, Von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001;159:137–44.CrossRefPubMed Koch W, Kastrati A, Bottiger C, Mehilli J, Von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001;159:137–44.CrossRefPubMed
13.
Zurück zum Zitat Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8.PubMed Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8.PubMed
14.
Zurück zum Zitat Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999;94(11):3941–6.PubMed Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999;94(11):3941–6.PubMed
15.
Zurück zum Zitat Mulligham CG, Petersdorf EW. Genomic polymorphism and allogeneic hematopoietic transplantation outcome. Biol Blood Marrow Transplant. 2006;12:19–27.CrossRef Mulligham CG, Petersdorf EW. Genomic polymorphism and allogeneic hematopoietic transplantation outcome. Biol Blood Marrow Transplant. 2006;12:19–27.CrossRef
16.
Zurück zum Zitat Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389(6652):737–42.CrossRefPubMed Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389(6652):737–42.CrossRefPubMed
17.
Zurück zum Zitat Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood. 1993;81(11):2964–71.PubMed Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood. 1993;81(11):2964–71.PubMed
18.
Zurück zum Zitat Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003;349:2201–10.CrossRefPubMed Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003;349:2201–10.CrossRefPubMed
19.
Zurück zum Zitat Ishikawa Y, Kashiwase K, Akaza K, Morishima Y, Inoko H, Sasazuki T, et al. Polymorphisms in TNFAand TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant. 2002;29:569–75.CrossRefPubMed Ishikawa Y, Kashiwase K, Akaza K, Morishima Y, Inoko H, Sasazuki T, et al. Polymorphisms in TNFAand TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant. 2002;29:569–75.CrossRefPubMed
20.
Zurück zum Zitat Kögler G, Middleton PG, Wilke M, Rocha V, Esendam B, Enczmann J, et al. Recipient cytokine genotypes for TNF-a and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GvHD in unrelated cord blood transplantation. Transplantation. 2002;74:1167–75.CrossRefPubMed Kögler G, Middleton PG, Wilke M, Rocha V, Esendam B, Enczmann J, et al. Recipient cytokine genotypes for TNF-a and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GvHD in unrelated cord blood transplantation. Transplantation. 2002;74:1167–75.CrossRefPubMed
21.
Zurück zum Zitat Socié G, Loiseau P, Tamouza R, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001;72(4):699–706.CrossRefPubMed Socié G, Loiseau P, Tamouza R, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001;72(4):699–706.CrossRefPubMed
22.
Zurück zum Zitat Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease. Hum Immunol. 2005;66(6):700–10.CrossRefPubMed Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease. Hum Immunol. 2005;66(6):700–10.CrossRefPubMed
23.
Zurück zum Zitat Hempel L, Körholz D, Nussbaum P, Bönig H, Burdach S, Zintl F. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant. 1997;20(5):365–8.CrossRefPubMed Hempel L, Körholz D, Nussbaum P, Bönig H, Burdach S, Zintl F. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant. 1997;20(5):365–8.CrossRefPubMed
24.
Zurück zum Zitat Min C-K, Lee WY, Min D-J, Lee D-G, Kim Y-J, Park YH, et al. The kinetics of circulationg cytokines including IL-6, TNF-α, IL-8 an IL-10 following allogenic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:935–40.CrossRefPubMed Min C-K, Lee WY, Min D-J, Lee D-G, Kim Y-J, Park YH, et al. The kinetics of circulationg cytokines including IL-6, TNF-α, IL-8 an IL-10 following allogenic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:935–40.CrossRefPubMed
25.
Zurück zum Zitat Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Tamura S, Wada H, et al. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation. Bone Marrow Transplant. 1999;24(9):1005–7.CrossRefPubMed Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Tamura S, Wada H, et al. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation. Bone Marrow Transplant. 1999;24(9):1005–7.CrossRefPubMed
Metadaten
Titel
Investigation of Functional IL-10 Gene Polymorphism and IL-10 Levels in Acute Graft-Versus-Host Disease
verfasst von
Renata Gonçalves Resende
Jeane de Fátima Correia-Silva
Telma Cristina Arão
Tarcília Aparecida Silva
Mauro Henrique Nogueira Guimarães Abreu
Henrique Bittencourt
Ricardo Santiago Gomez
Publikationsdatum
01.05.2010
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 3/2010
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-010-9377-6

Weitere Artikel der Ausgabe 3/2010

Journal of Clinical Immunology 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.